Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dihydroergotamine mesilate - POZEN

Next Previous
Drug Profile

Dihydroergotamine mesilate - POZEN

Alternative Names: Dihydroergotamine mesylate injection - POZEN; MT-300

Latest Information Update: 18 Jul 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator POZEN
  • Class 3-ring heterocyclic compounds; Alcohols; Amides; Antimigraines; Benzene derivatives; Ergotamines; Heterocyclic compounds with 4 or more rings; Indoles; Ketones; Mesylates; Oxazolidinones; Piperazines; Piperidines; Pyrrolidines; Quinolines; Small molecules
  • Mechanism of Action Serotonin 1B receptor agonists; Serotonin 1D receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Migraine

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 02 Mar 2005 Xcel Pharmaceuticals has been acquired by, and merged into, Valeant Pharmaceuticals International
  • 04 Nov 2004 Preregistration for Migraine in USA (Injection)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top